These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 3825226

  • 1. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M, Beermann J, Gerckens U, Lüderitz B.
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [Abstract] [Full Text] [Related]

  • 2. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P, Manz M, Schütz R, Lüderitz B.
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [Abstract] [Full Text] [Related]

  • 3. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L.
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [Abstract] [Full Text] [Related]

  • 4. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V, Mewis C, Mayer F, Seipel L.
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK, Prasad GS, Mohan JC, Arora R, Khalilullah M.
    Indian Heart J; 1991 Oct; 43(1):5-10. PubMed ID: 1894303
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [Abstract] [Full Text] [Related]

  • 9. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
    [Abstract] [Full Text] [Related]

  • 10. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
    Li Q, Wang Z, Peng D.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Aug; 22(2):123-6. PubMed ID: 9868052
    [Abstract] [Full Text] [Related]

  • 11. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [Abstract] [Full Text] [Related]

  • 12. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
    Schwab JO, Eichner G, Schmitt H, Schrickel J, Yang A, Balta O, Lüderitz B, Lewalter T.
    Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
    [Abstract] [Full Text] [Related]

  • 13. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H, Kühnert H, Dannberg G, Küch N, Büttner A.
    Z Gesamte Inn Med; 1989 Dec 01; 44(23):707-11. PubMed ID: 2629366
    [Abstract] [Full Text] [Related]

  • 14. Diprafenone for treatment of Wolff-Parkinson-White syndrome.
    Kunze KP, Schlüter M, Geiger M, Kuck KH.
    Cardiovasc Drugs Ther; 1989 Mar 01; 3(1):73-9. PubMed ID: 2487525
    [Abstract] [Full Text] [Related]

  • 15. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M.
    Indian Heart J; 1996 Mar 01; 48(2):133-7. PubMed ID: 8682552
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
    Roy D, Marchand E, Chabot M, Gagné P, Waters DD, Bourassa MG.
    Can J Cardiol; 1985 Mar 01; 1(5):302-5. PubMed ID: 3842093
    [Abstract] [Full Text] [Related]

  • 17. Ventricular tachycardia with QRS configuration similar to that in sinus rhythm and a myocardial origin: differential diagnosis with bundle branch reentry.
    Guo H, Hecker S, Lévy S, Olshansky B.
    Europace; 2001 Apr 01; 3(2):115-23. PubMed ID: 11333048
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
    Stiles MK, Sanders P, Disney P, Brooks A, John B, Lau DH, Shashidhar, Wilson L, Mackenzie L, Young GD.
    Am J Cardiol; 2007 Oct 15; 100(8):1249-53. PubMed ID: 17920366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.